abstract |
The present invention relates to peptides capable of binding to ICE and / or enzymes of the ICE family, despite the fact that this peptide contains the amino acid sequence of SEQ ID NO: 1 given in the sequence listing, in which Xaa is selected from aspartic acid and alanine, optionally containing one or more amino acids at its N-terminus and / or C-terminus. It also relates to the use of these peptides for the preparation of pharmaceutical compositions active in diseases requiring ICE inhibition and / or inhibition of enzymes of the ICE family. The international application was published together with an international search report. |